1 – 26 of 26
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
(
- Contribution to journal › Article
-
Mark
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting
(
- Contribution to journal › Article
-
Mark
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin
(
- Contribution to journal › Article
-
Mark
Imaging the Tumor Antioxidant Response with [18F]FSPG PET
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria
(
- Contribution to journal › Article
- 2023
-
Mark
Tumor Control Probability and Small-Scale Monte Carlo Dosimetry : Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy
(
- Contribution to journal › Article
-
Mark
Evaluation of enhanced permeability effect and different linear energy transfer of radionuclides in a prostate cancer xenograft model
(
- Contribution to journal › Article
-
Mark
Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography
2023) In bioRxiv : the preprint server for biology(
- Working paper/Preprint › Preprint in preprint archive
- 2022
-
Mark
Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617
(
- Contribution to journal › Article
-
Mark
Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3
(
- Contribution to journal › Article
- 2021
-
Mark
177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging
(
- Contribution to journal › Article
-
Mark
Kidney protection with the radical scavenger α1-microglobulin (A1m) during peptide receptor radionuclide and radioligand therapy
(
- Contribution to journal › Article
-
Mark
A conjugation strategy to modulate antigen binding and FcRn interaction leads to improved tumor targeting and radioimmunotherapy efficacy with an antibody targeting prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Humanization, radiolabeling and biodistribution studies of an igg1-type antibody targeting uncomplexed psa for theranostic applications
(
- Contribution to journal › Article
- 2019
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
(
- Contribution to journal › Article
- 2018
-
Mark
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide 177Lu Compared to Alpha Particles and Gamma Rays.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
(
- Contribution to journal › Scientific review
-
Mark
Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
(
- Contribution to journal › Article
-
Mark
High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors
(
- Contribution to journal › Article
- 2015
-
Mark
Intratherapeutic Biokinetic Measurements, Dosimetry Parameters Estimate, and Monitoring Treatment Efficacy using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy.
(
- Contribution to journal › Article
-
Mark
Diffuse reflectance spectroscopy of liver tissue
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(
- Contribution to journal › Article
- 2014
-
Mark
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a In-111-radiolabelled monoclonal antibody, 11B6
(
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer Preclinical evaluation of kallikrein related peptidase 2 targeting
2014)(
- Thesis › Doctoral thesis (monograph)